Mass spectrometric study of variation in kinin peptide profiles in nasal fluids and plasma of adult healthy individuals.

Tanja GangnusAnke BartelBjoern Bengt Burckhardt

Published in: Journal of translational medicine (2022)

This well-characterized healthy cohort enables investigation of the potential of kinins as biomarkers and would provide a valid control group to study alterations of kinin profiles in diseases, such as angioedema, sepsis, stroke, Alzheimer's disease, and COVID-19.

Keyphrases

sars cov
coronavirus disease
acute kidney injury
cognitive decline
young adults
risk assessment
mild cognitive impairment
brain injury